Highland Capital Management (Texas)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-27,000
Closed -$1.72M – 336
2019
Q1
$1.72M Sell
27,000
-12,000
-31% -$685K 0.11% 163
2018
Q4
$1.99M Buy
+39,000
New +$1.97M 0.15% 117
2018
Q2
– Sell
-36,000
Closed -$1.67M – 344
2018
Q1
$1.67M Buy
+36,000
New +$1.56M 0.09% 147
2017
Q3
– Sell
-175,500
Closed -$6.92M – 316
2017
Q2
$6.92M Buy
+175,500
New +$6.41M 0.29% 75
2017
Q1
– Sell
-71,697
Closed -$2.24M – 299
2016
Q4
$2.24M Buy
71,697
+52,623
+276% +$1.71M 0.11% 139
2016
Q3
$767K Sell
19,074
-195,603
-91% -$7.37M 0.02% 203
2016
Q2
$7.14M Buy
214,677
+63,885
+42% +$2.19M 0.29% 95
2016
Q1
$4.43M Sell
150,792
-328,116
-69% -$9.05M 0.2% 122
2015
Q4
$12.6M Sell
478,908
-636,762
-57% -$16.5M 0.4% 76
2015
Q3
$26.4M Buy
1,115,670
+305,358
+38% +$7.37M 0.77% 39
2015
Q2
$19.2M Buy
810,312
+139,458
+21% +$3.15M 0.39% 65
2015
Q1
$15.9M Buy
670,854
+199,854
+42% +$4.48M 0.33% 76
2014
Q4
$10M Buy
471,000
+395,550
+524% +$7.95M 0.33% 74
2014
Q3
$1.28M Sell
75,450
-60,150
-44% -$950K 0.05% 161
2014
Q2
$1.94M Hold
135,600
– – 0.07% 142
2014
Q1
$1.68M Hold
135,600
– – 0.07% 135
2013
Q4
$1.49M Hold
135,600
– – 0.08% 90
2013
Q3
$1.57M Hold
135,600
– – 0.1% 87
2013
Q2
$1.52M Buy
+135,600
New +$1.61M 0.12% 84

Other funds holding EW

Highland Capital Management (Texas)'s EW Position: Q2 2019 in Review

Highland Capital Management (Texas) sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 27,000 shares — an estimated $1.72M sold.

Highland Capital Management (Texas) first reported a position in EW in Q2 2013 and held it in 19 quarters. The position peaked at $26.4M in Q3 2015. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

  • Highland Capital Management (Texas) reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 27,000 Edwards Lifesciences shares in Q2 2019, an estimated $1.72M.
  • Highland Capital Management (Texas) first reported a position in Edwards Lifesciences in Q2 2013 and held it in 19 quarters.
  • Highland Capital Management (Texas)'s Edwards Lifesciences position peaked at $26.4M in Q3 2015.
  • 921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.